Texte intégral

• Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001; 24(6): 1069-78. http://dx.doi.org/10.2337/diacare.24.6.1069 PMID: 11375373
• Barnard KD, Skinner TC, Peveler R. The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature re-view. Diabet Med 2006; 23(4): 445-8. http://dx.doi.org/10.1111/j.1464-5491.2006.01814.x PMID: 16620276
• Roy T, Lloyd CE. Epidemiology of depression and diabetes: A systematic review. J Affect Disord 2012; 142(Suppl.): S8-S21. http://dx.doi.org/10.1016/S0165-0327(12)70004-6 PMID: 23062861
• Lloyd CE, Nouwen A, Sartorius N, et al. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabet Med 2018; 35(6): 760-9. http://dx.doi.org/10.1111/dme.13611 PMID: 29478265
• Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care 2000; 23(7): 934-42. http://dx.doi.org/10.2337/diacare.23.7.934 PMID: 10895843
• Schmitz N, Gariépy G, Smith KJ, et al. Recurrent subthreshold depression in type 2 diabetes: An important risk factor for poor health outcomes. Diabetes Care 2014; 37(4): 970-8. http://dx.doi.org/10.2337/dc13-1832 PMID: 24198303
• Nouwen A, Adriaanse MC, Dam K, et al. Longitudinal associations between depression and diabetes complications: A systematic review and meta‐analysis. Diabet Med 2019; 36(12): 1562-72. http://dx.doi.org/10.1111/dme.14054 PMID: 31215077
• Farooqi A, Khunti K, Abner S, Gillies C, Morriss R, Seidu S. Comorbid depression and risk of cardiac events and cardiac mortality in people with diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2019; 156: 107816. http://dx.doi.org/10.1016/j.diabres.2019.107816 PMID: 31421139
• van Dooren FEP, Nefs G, Schram MT, Verhey FRJ, Denollet J, Pouwer F. Depression and risk of mortality in people with diabetes mellitus: A systematic review and meta-analysis. PLoS One 2013; 8(3): e57058. http://dx.doi.org/10.1371/journal.pone.0057058
• Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28(11): 2668-72. http://dx.doi.org/10.2337/diacare.28.11.2668 PMID: 16249537
• Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care 2008; 31(12): 2398-403. http://dx.doi.org/10.2337/dc08-1341 PMID: 19033420
• Russo VC, Higgins S, Werther GA, Cameron FJ. Effects of fluctu-ating glucose levels on neuronal cells in vitr. Neurochem Res 2012; 37(8): 1768-82. http://dx.doi.org/10.1007/s11064-012-0789-y PMID: 22565596
• Moulton CD, Costafreda SG, Horton P, Ismail K, Fu CHY. Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav 2015; 9(4): 651-62. http://dx.doi.org/10.1007/s11682-014-9348-2 PMID: 25563229
• Penckofer S, Quinn L, Byrn M, Ferrans C, Miller M, Strange P. Does glycemic variability impact mood and quality of life? Diabetes Technol Ther 2012; 14(4): 303-10. http://dx.doi.org/10.1089/dia.2011.0191 PMID: 22324383
• Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: Time for an appraisal. Lancet Diabetes Endocrinol 2015; 3(6): 450-60. http://dx.doi.org/10.1016/S2213-8587(15)00135-7 PMID: 25995123
• Li H, Wang A, Feng W, et al. Prospective study of glycated hemoglobin and trajectories of depressive symptoms: The China health and retirement longitudinal study. Aging Dis 2019; 10(2): 249-57. http://dx.doi.org/10.14336/AD.2018.0410 PMID: 31011476
• Trief PM, Foster NC, Chaytor N, et al. Longitudinal changes in depression symptoms and glycemia in adults with type 1 diabetes. Diabetes Care 2019; 42(7): 1194-201. http://dx.doi.org/10.2337/dc18-2441 PMID: 31221694
• Geraets AFJ, Köhler S, Muzambi R, et al. The association of hy-perglycaemia and insulin resistance with incident depressive symptoms over 4 years of follow-up: The Maastricht Study. Diabetolo-gia 2020; 63(11): 2315-28. http://dx.doi.org/10.1007/s00125-020-05247-9 PMID: 32757152
• van der Feltz-Cornelis C, Allen SF, Holt RIG, Roberts R, Nouwen A, Sartorius N. Treatment for comorbid depressive disorder or sub-threshold depression in diabetes mellitus: Systematic review and meta‐analysis. Brain Behav 2021; 11(2): e01981. http://dx.doi.org/10.1002/brb3.1981 PMID: 33274609
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021; 372(71): n71. http://dx.doi.org/10.1136/bmj.n71 PMID: 33782057
• Higgins JPT, Green S, Eds. Cochrane handbook for systematic reviews of interventions: Cochrane book series. 1st ed. Chichester, UK: John Wiley & Sons, Ltd 2008.
• Amsberg S, Anderbro T, Wredling R, et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients—A randomized controlled trial. Patient Educ Couns 2009; 77(1): 72-80. http://dx.doi.org/10.1016/j.pec.2009.01.015 PMID: 19297117
• Anderson RT, Narayan KMV, Feeney P, et al. Effect of intensive glycemic lowering on health-related quality of life in type 2 diabe-tes: ACCORD trial. Diabetes Care 2011; 34(4): 807-12. http://dx.doi.org/10.2337/dc10-1926 PMID: 21346183
• Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358(24): 2545-59. http://dx.doi.org/10.1056/NEJMoa0802743 PMID: 18539917
• Bluml BM, Kolb LE, Lipman R. Evaluating the impact of year-long, augmented diabetes self-management support. Popul Health Manag 2019; 22(6): 522-8. http://dx.doi.org/10.1089/pop.2018.0175 PMID: 30668228
• Fisher L, Polonsky W, Parkin CG, Jelsovsky Z, Amstutz L, Wagner RS. The impact of blood glucose monitoring on depression and distress in insulin-naïve patients with type 2 diabetes. Curr Med Res Opin 2011; 27(sup3)(Suppl. 3): 39-46. http://dx.doi.org/10.1185/03007995.2011.619176 PMID: 21916532
• Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: Results from the Structured Testing Program study. Diabetes Care 2011; 34(2): 262-7. http://dx.doi.org/10.2337/dc10-1732 PMID: 21270183
• Gary TL, Baptiste-Roberts K, Crum RM, Cooper LA, Ford DE, Brancati FL. Changes in depressive symptoms and metabolic control over 3 years among African Americans with type 2 diabetes. Int J Psychiatry Med 2005; 35(4): 377-82. http://dx.doi.org/10.2190/BQ22-4HU0-P6EK-L7YX PMID: 16673837
• Gary TL, Bone LR, Hill MN, et al. Randomized controlled trial of the effects of nurse case manager and community health worker interventions on risk factors for diabetes-related complications in ur-ban African Americans. Prev Med 2003; 37(1): 23-32. http://dx.doi.org/10.1016/S0091-7435(03)00040-9 PMID: 12799126
• Khodneva Y, Safford MM, Richman J, Gamboa C, Andreae S, Cherrington A. Volunteer peer support, diabetes, and depressive symptoms: Results from the ENCOURAGE trial. J Clin Transl En-docrinol 2016; 4: 38-44. http://dx.doi.org/10.1016/j.jcte.2016.04.002 PMID: 29159129
• Safford MM, Andreae S, Cherrington AL, et al. Peer coaches to improve diabetes outcomes in rural Alabama: A cluster randomized trial. Ann Fam Med 2015; 13(Suppl 1)(Suppl. 1): S18-26. http://dx.doi.org/10.1370/afm.1798 PMID: 26304967
• Leyva B, Zagarins SE, Allen NA, Welch G. The relative impact of diabetes distress vs depression on glycemic control in hispanic patients following a diabetes self-management education interven-tion. Ethn Dis 2011; 21(3): 322-7. PMID: 21942165
• Welch G, Zagarins SE, Feinberg RG, Garb JL. Motivational inter-viewing delivered by diabetes educators: Does it improve blood glucose control among poorly controlled type 2 diabetes patients? Diabetes Res Clin Pract 2011; 91(1): 54-60. http://dx.doi.org/10.1016/j.diabres.2010.09.036 PMID: 21074887
• Malanda UL, Bot SDM, Kostense PJ, Snoek FJ, Dekker JM, Nijpels G. Effects of self-monitoring of glucose on distress and self-efficacy in people with non-insulin-treated Type 2 diabetes: A randomized controlled trial. Diabet Med 2016; 33(4): 537-46. http://dx.doi.org/10.1111/dme.12849 PMID: 26171942
• Presley C, Agne A, Shelton T, Oster R, Cherrington A. Mobile-enhanced peer support for african americans with Type 2 diabetes: A randomized controlled trial. J Gen Intern Med 2020; 35(10): 2889-96. http://dx.doi.org/10.1007/s11606-020-06011-w PMID: 32700215
• Rosland AM, Kieffer E, Spencer M, et al. Do pre-existing diabetes social support or depressive symptoms influence the effectiveness of a diabetes management intervention? Patient Educ Couns 2015; 98(11): 1402-9. http://dx.doi.org/10.1016/j.pec.2015.05.019 PMID: 26234800
• Spencer MS, Rosland AM, Kieffer EC, et al. Effectiveness of a community health worker intervention among African American and Latino adults with type 2 diabetes: A randomized controlled trial. Am J Public Health 2011; 101(12): 2253-60. http://dx.doi.org/10.2105/AJPH.2010.300106 PMID: 21680932
• der Ven NCW, Hogenelst MHE, Tromp-Wever AME, et al. Short-term effects of cognitive behavioural group training (CBGT) in adult Type 1 diabetes patients in prolonged poor glycaemic control. A randomized controlled trial. Diabet Med 2005; 22(11): 1619-23. http://dx.doi.org/10.1111/j.1464-5491.2005.01691.x PMID: 16241932
• Wang ML, Lemon SC, Whited MC, Rosal MC. Who benefits from diabetes self-management interventions? The influence of depression in the Latinos en Control trial. Ann Behav Med 2014; 48(2): 256-64. http://dx.doi.org/10.1007/s12160-014-9606-y PMID: 24664615
• Rosal MC, Ockene IS, Restrepo A, et al. Randomized trial of a literacy-sensitive, culturally tailored diabetes self-management intervention for low-income latinos: Latinos en control. Diabetes Care 2011; 34(4): 838-44. http://dx.doi.org/10.2337/dc10-1981 PMID: 21378213
• Beran M, Muzambi R, Geraets A, et al. The bidirectional longitudinal association between depressive symptoms and HbA1c: A systematic review and meta‐analysis. Diabet Med 2022; 39(2): e14671. http://dx.doi.org/10.1111/dme.14671 PMID: 34407250
• van Agtmaal MJM, Houben AJHM, Pouwer F, Stehouwer CDA, Schram MT. Association of microvascular dysfunction with late--life depression: A systematic review and meta-analysis. JAMA Psychiatry 2017; 74(7): 729-39. http://dx.doi.org/10.1001/jamapsychiatry.2017.0984 PMID: 28564681
• Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: The search for shared mechanisms. Lancet Diabetes Endocrinol 2015; 3(6): 461-71. http://dx.doi.org/10.1016/S2213-8587(15)00134-5 PMID: 25995124
• Van Sloten T, Schram M. Understanding depression in type 2 diabetes: A biological approach in observational studies F1000Res 2018; 7: 1283.
• Lloyd CE, Sartorius N, Ahmed HU, et al. Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: Results from the INTERPRET-DD prospective study. Epidemiol Psychiatr Sci 2020; 29(e134): e134. http://dx.doi.org/10.1017/S2045796020000438 PMID: 32484148
• Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: A call for greater clarity and precision. Diabet Med 2014; 31(7): 764-72. http://dx.doi.org/10.1111/dme.12428 PMID: 24606397-